low-grade oligodendroglioma
Showing 1 - 25 of >10,000
High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)
Not yet recruiting
- High-grade Glioma
- +3 more
- Low-dose OKN-007, BID
- +3 more
- (no location specified)
Sep 26, 2022
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)
Recruiting
- Oligodendroglioma
- +2 more
- PCV chemotherapy
- Radiotherapy and PCV chemotherapy
-
Amiens, France
- +25 more
Jun 14, 2022
Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,
Terminated
- Low Grade Glioma
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 3, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,
Active, not recruiting
- Adult Anaplastic Astrocytoma
- +15 more
- biopsy
- +7 more
-
Rochester, MinnesotaMayo Clinic
Apr 8, 2022
Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)
Recruiting
- Glioblastoma
- +3 more
- Adaptive Radiotherapy
-
New York, New YorkColumbia University Irving Medical Center
Oct 27, 2023
Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)
Completed
- Adult Brain Tumor
- +11 more
- proton beam radiation therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Dec 8, 2020
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous
Completed
- Adult Diffuse Astrocytoma
- +4 more
- tumor lysate-pulsed autologous dendritic cell vaccine
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Oct 14, 2020
Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)
Recruiting
- Oligodendroglioma
- Tislelizumab plus Bevacizumab
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Aug 21, 2022
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022
Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,
Recruiting
- Anaplastic Astrocytoma, IDH-Wildtype
- +8 more
- Quality-of-Life Assessment
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 8, 2022
Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by
Recruiting
- Recurrent High-grade Glioma
- +3 more
- 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
- +2 more
-
Incheon, Korea, Republic ofGachon University Gil Medical Center
Feb 19, 2023
Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an
Completed
- Glioma
- +7 more
- Neural stem cells loaded with an oncolytic adenovirus
-
Duarte, California
- +1 more
Dec 28, 2022
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Low-grade Glioma Trial in Toronto (Saturation Transfer (ST)-MRI)
Recruiting
- Low-grade Glioma
- Saturation Transfer (ST)-MRI
-
Toronto, Ontario, Canada
- +1 more
Aug 10, 2023
Astrocytoma, Oligodendroglioma, Oligodendroastrocytoma Trial in Guangzhou (Radiotherapy, Temozolomide)
Recruiting
- Astrocytoma
- +2 more
- Radiotherapy
- Temozolomide
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 26, 2020
Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in San Francisco (Everolimus, Archival Tissue
Completed
- Adult Diffuse Astrocytoma
- +4 more
- Everolimus
- Archival Tissue Analysis
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 24, 2020
Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)
Not yet recruiting
- Low-grade Oral Dysplasia
- Probiotic oral lozenges
- Standard of care for oral dysplasia
-
Boston, MassachusettsBoston Medical Center
Jan 22, 2023
Low Grade Serous Ovarian Carcinoma and Uterine Involvement :
Completed
- Serous Ovarian Carcinoma
- Low Grade Serous Ovarian Carcinoma
- Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
-
Lyon, FranceHospices civils de Lyon
Feb 14, 2023
HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)
Recruiting
- HPV-Related Cervical Carcinoma
- +3 more
- CO2
-
Wenzhou, Zhejiang, Chinafirst affiliated hospital of Wenzhou medical university
Sep 23, 2023
Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))
Recruiting
- Astrocytoma
- +2 more
- temporally-modulated pulsed radiotherapy (TMPRT)
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023